Top Section/Ad
Top Section/Ad
Most recent
TAO Alpha helps bring Bitcoin acquisition convertibles to European market
Autodoc postpones IPO, cites “geopolitical situation”
Second sizeable French ECM deal this week after Ayvens block
Innoscripta listing a rare miss in hot market
More articles/Ad
More articles/Ad
More articles
-
United Laboratories International Holdings returned to the equity-linked market in style on Monday after a five year absence, raising $130m from a convertible bond. -
Financial markets have changed their whole investment mindset in the past seven days, as lightly as an actor changing clothes. Out has gone lower-for-longer pessimism and slavery to central banks; in has come a belief in growth and enthusiasm for higher rates and inflation, writes Jon Hay.
-
Last week’s shock US election result caused a rout in emerging markets, with stocks and currencies in southeast Asia among the hardest hit. But unlike in the past, this has not brought equity capital markets activity to a standstill, as share sales in Indonesia, the Philippines and Thailand showed this week. John Loh reports.
-
Deutsche Bank’s head of equity-linked origination for Asia is transitioning to a new role within the firm, according to sources close to the matter.
-
Bayer successfully pulled off what was arguably this year’s biggest European ECM deal on Tuesday night, with a €4bn mandatory convertible and €1.5bn delta equity placement. But although both were fully sold and have traded stably, a good number of deal-playing investors are still putting in small orders.
-
Bayer, the German life sciences group, picked Tuesday night to launch the first part of its $19bn equity financing for its $66bn takeover of Monsanto. Bayer's deal comes as equity markets are revitalised by the new conviction that Western policy is shifting to reflation.
